These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 11005269

  • 1. Intersubject responsiveness of high-affinity growth hormone (GH)-binding protein (GHBP) to long-term GH replacement therapy.
    De Vries WR, Koppeschaar HP, Bol E, Roelen CA, Donker GH, Doerga ME, Osman-Dualeh M, Snel YE.
    J Endocrinol Invest; 2000; 23(7):449-56. PubMed ID: 11005269
    [Abstract] [Full Text] [Related]

  • 2. High-affinity growth hormone (GH)-binding protein (GHBP), body fat mass, and insulin-like growth factor-binding protein-3 predict the GHBP response to GH therapy in adult GH deficiency syndrome.
    Roelen CA, Koppeschaar HP, de Vries WR, Doerga ME, Snel YE, Bol E, Zelissen PM, Thijssen JH, Blankenstein MA.
    Metabolism; 1999 Mar; 48(3):314-8. PubMed ID: 10094106
    [Abstract] [Full Text] [Related]

  • 3. Impact of gender and androgen status on IGF-I levels in normal and GH-deficient adults.
    Fisker S, Jorgensen JO, Vahl N, Orskov H, Christiansen JS.
    Eur J Endocrinol; 1999 Dec; 141(6):601-8. PubMed ID: 10601963
    [Abstract] [Full Text] [Related]

  • 4. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K, Kato Y, Kohno H, Takano K, Tanaka T, Teramoto A, Shimatsu A.
    Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
    [Abstract] [Full Text] [Related]

  • 5. Growth hormone (GH) substitution for one year normalizes elevated GH-binding protein levels in GH-deficient adults secondary to a reduction in body fat. A placebo-controlled trial.
    Fisker S, Vahl N, Hansen TB, Jørgensen JO, Hagen C, Orskov H, Christiansen JS.
    Growth Horm IGF Res; 1998 Apr; 8(2):105-12. PubMed ID: 10987677
    [Abstract] [Full Text] [Related]

  • 6. Growth hormone binding protein correlates strongly with leptin and percentage body fat in GH-deficient adults, is increased by GH replacement but does not predict IGF-I response.
    Florkowski CM, Barnard R, Livesey JH, Veveris T, Espiner EA, Donald RA.
    Growth Horm IGF Res; 1999 Feb; 9(1):35-40. PubMed ID: 10207506
    [Abstract] [Full Text] [Related]

  • 7. Growth hormone (GH)-binding protein in prepubertal short children born small for gestational age: effects of growth hormone treatment. Swedish Study Group for Growth Hormone Treatment.
    Boguszewski M, Bjarnason R, Rosberg S, Carlsson LM, Albertsson-Wikland K.
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1014-9. PubMed ID: 9100566
    [Abstract] [Full Text] [Related]

  • 8. Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women.
    Khorram O, Laughlin GA, Yen SS.
    J Clin Endocrinol Metab; 1997 May; 82(5):1472-9. PubMed ID: 9141536
    [Abstract] [Full Text] [Related]

  • 9. The study of spontaneous GH secretion after 36-h fasting distinguishes between GH-deficient and normal adults.
    Aimaretti G, Colao A, Corneli G, Pivonello R, MacCario M, Morrison K, Pflaum CD, Strasburger CJ, Lombardi G, Ghigo E.
    Clin Endocrinol (Oxf); 1999 Dec; 51(6):771-7. PubMed ID: 10619983
    [Abstract] [Full Text] [Related]

  • 10. Systemic ghrelin levels in subjects with growth hormone deficiency are not modified by one year of growth hormone replacement therapy.
    Janssen JA, van der Toorn FM, Hofland LJ, van Koetsveld P, Broglio F, Ghigo E, Lamberts SW, Jan van der Lely A.
    Eur J Endocrinol; 2001 Dec; 145(6):711-6. PubMed ID: 11720895
    [Abstract] [Full Text] [Related]

  • 11. High-affinity growth hormone binding protein, insulin-like growth factor I and insulin-like growth factor binding protein 3 in adults with growth hormone deficiency.
    Roelen CA, Koppeschaar HP, de Vries WR, Zelissen PM, Snel YE, Doerga ME, Thijssen JH, Blankenstein RA.
    Eur J Endocrinol; 1996 Jul; 135(1):82-6. PubMed ID: 8765978
    [Abstract] [Full Text] [Related]

  • 12. Insulin-like growth factor-I response to a single bolus of growth hormone is increased in obesity.
    Gleeson HK, Lissett CA, Shalet SM.
    J Clin Endocrinol Metab; 2005 Feb; 90(2):1061-7. PubMed ID: 15522943
    [Abstract] [Full Text] [Related]

  • 13. Growth hormone (GH) provocative retesting of 108 young adults with childhood-onset GH deficiency and the diagnostic value of insulin-like growth factor I (IGF-I) and IGF-binding protein-3.
    Juul A, Kastrup KW, Pedersen SA, Skakkebaek NE.
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1195-201. PubMed ID: 9100596
    [Abstract] [Full Text] [Related]

  • 14. Serum insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit as serum markers of body composition during growth hormone (GH) therapy in adults with GH deficiency.
    Thorén M, Hilding A, Baxter RC, Degerblad M, Wivall-Helleryd IL, Hall K.
    J Clin Endocrinol Metab; 1997 Jan; 82(1):223-8. PubMed ID: 8989263
    [Abstract] [Full Text] [Related]

  • 15. The individual responsiveness to growth hormone (GH) treatment in GH-deficient adults is dependent on the level of GH-binding protein, body mass index, age, and gender.
    Johannsson G, Bjarnason R, Bramnert M, Carlsson LM, Degerblad M, Manhem P, Rośen T, Thorén M, Bengtsson BA.
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1575-81. PubMed ID: 8636370
    [Abstract] [Full Text] [Related]

  • 16. Serum levels of insulin-like growth factor binding proteins (IGFBP)-4 and -5 correlate with bone mineral density in growth hormone (GH)-deficient adults and increase with GH replacement therapy.
    Thorén M, Hilding A, Brismar T, Magnusson P, Degerblad M, Larsson L, Sääf M, Baylink DJ, Mohan S.
    J Bone Miner Res; 1998 May; 13(5):891-9. PubMed ID: 9610754
    [Abstract] [Full Text] [Related]

  • 17. National Cooperative Growth Study substudy VI: the clinical utility of growth-hormone-binding protein, insulin-like growth factor I, and insulin-like growth factor-binding protein 3 measurements.
    Attie KM, Julius JR, Stoppani C, Rundle AC.
    J Pediatr; 1997 Jul; 131(1 Pt 2):S56-60. PubMed ID: 9255230
    [Abstract] [Full Text] [Related]

  • 18. A low starting dose of genotropin in growth hormone-deficient adults.
    Janssen YJ, Frölich M, Roelfsema F.
    J Clin Endocrinol Metab; 1997 Jan; 82(1):129-35. PubMed ID: 8989246
    [Abstract] [Full Text] [Related]

  • 19. Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease.
    Fernholm R, Bramnert M, Hägg E, Hilding A, Baylink DJ, Mohan S, Thorén M.
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4104-12. PubMed ID: 11095440
    [Abstract] [Full Text] [Related]

  • 20. Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults.
    Marzullo P, Di Somma C, Pratt KL, Khosravi J, Diamandis A, Lombardi G, Colao A, Rosenfeld RG.
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3001-8. PubMed ID: 11443159
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.